Side Effects
- Black, tarry stools.
- bloating or swelling of the face, arms, hands, lower legs, or feet.
- blood in the urine or stools.
- chest pain.
- cloudy urine.
- coughing up blood.
- difficult or labored breathing.
- difficulty in moving.
What class of chemotherapy is gemcitabine?
Nucleoside
Gemcitabine/Classification
Is pancreatic a terminal?
Despite the overall poor prognosis and the fact that the disease is mostly incurable, pancreatic cancer has the potential to be curable if caught very early. Up to 10 percent of patients who receive an early diagnosis become disease-free after treatment.
Is gemcitabine a prodrug?
Gemcitabine is a synthetic pyrimidine nucleoside prodrug—a nucleoside analog in which the hydrogen atoms on the 2′ carbon of deoxycytidine are replaced by fluorine atoms.
Does gemcitabine weaken the immune system?
Thus, gemcitabine does not appear to be detrimental to specific antitumor cellular immunity and may be useful in combination chemo-immunotherapy protocols. In contrast, vaccination protocols requiring a humoral immune response for maximal efficacy may be compromised in patients treated with gemcitabine.
How quickly does gemcitabine work?
How you have gemcitabine. You have gemcitabine into your bloodstream. It takes about 30 minutes.
How long can you take gemcitabine?
How long does treatment take? A cycle (dose) of gemcitabine, with paclitaxel, lasts 21 days. Gemcitabine is given on days one and eight of the cycle. The time between each cycle of treatment gives your body time to recover.
What is end stage chronic pancreatitis?
The end stage is characterized by steatorrhea and insulin-dependent diabetes mellitus. Several characteristic complications of chronic pancreatitis are known such as common bile duct, duodenal, main pancreatic duct and vascular obstruction/stenosis. Chronic pancreatitis represents a risk factor for pancreatic cancer.
How long does it take for gemcitabine to work?
Can chemotherapy shrink pancreatic tumors?
Locally advanced pancreatic cancer You should be offered chemotherapy, and sometimes chemoradiotherapy. This may shrink the cancer and slow down its growth. For a small number of people, this treatment may shrink the cancer enough to make surgery possible.
How many patients with pancreatic adenocarcinoma are included in GEMOX?
A total of 33 patients (median age of 57) were included with lo … Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study Br J Cancer. 2006 Feb 27;94(4):481-5.doi: 10.1038/sj.bjc.6602966.
Is opengemox effective for advanced pancreatic cancer?
GEMOX is a well-tolerated, active regimen that may provide a benefit to patients with advanced pancreatic cancer after progression following standard gemcitabine treatment. Publication types Clinical Trial, Phase II
Is gem alone effective for advanced pancreatic cancer?
Gemcitabine (Gem) is the standard treatment for advanced pancreatic cancer. Given the promising phase II results obtained with the Gem-oxaliplatin (GemOx) combination, we conducted a phase III study comparing GemOx with Gem alone in advanced pancreatic cancer.
What is the GemOx regimen?
The GEMOX regimen consisted of 1000 mg m(-2) of GEM at a 100-min infusion on day 1, followed on day 2 by 100 mg m(-2) of oxaliplatin at a 2-h infusion; a cycle that was given every 2 weeks. All patients received at least one cycle of GEMOX (median 5; range 1-29).